- 2024-08-20 01:49抑制剂Bupranolol|Bupranolol|14556-46-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:49抑制剂Bupranolol|Bupranolol|14556-46-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:49抑制剂Bupranolol|Bupranolol|14556-46-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:49抑制剂Buloxibutid|Buloxibutid|477775-14-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:49抑制剂Buloxibutid|Buloxibutid|477775-14-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:49抑制剂BTZ043|BTZ043|1161233-85-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:49抑制剂BS-181|BS-181|1092443-52-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:49抑制剂BS-181|BS-181|1092443-52-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:49抑制剂BTZ043|BTZ043|1161233-85-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:49抑制剂BTZ043|BTZ043|1161233-85-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:49抑制剂Bruceantinol|Bruceantinol|53729-52-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:49抑制剂Bruceantinol|Bruceantinol|53729-52-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:49抑制剂Bruceantinol|Bruceantinol|53729-52-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:49抑制剂BS-181|BS-181|1092443-52-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:49抑制剂BRL-15572 dihydrochloride|BRL-15572 dihydrochloride|193611-72-2|Adamas life|≥98%（以实测数值为准）|BR|100m
- 2024-08-20 01:49抑制剂BRL-15572 dihydrochloride|BRL-15572 dihydrochloride|193611-72-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:49抑制剂BRL-15572 dihydrochloride|BRL-15572 dihydrochloride|193611-72-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:49抑制剂BRD7116|BRD7116|329059-55-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:49抑制剂BRD7116|BRD7116|329059-55-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:49抑制剂BRD9876|BRD9876|32703-82-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
